Researchers have been conducting researcher trials for medicines that make cancer patients receive positive treatments that will prolong many patients life expectancy. There are many know drugs that will shrink the size of cancerous tumors with in the affected areas. Also more DNA testing is being performed for all phases and types of cancers. Screening for damaged cells allows scientists to treat the damaged cells and ultimately blood infuse them into the patient and research how they react.
A very rare type of cancer called mesothelioma. Majority, over 80% of mesothelioma is cause by the exposure to asbestos fibers that are inhaled. The unfortunate part of this disease is that you do not start experiencing symptoms of mesothelioma until decades after initial exposure. From diagnosis of this disease patient have approximately 2-4 months to live.
For years scientist and researchers have tried numerous drugs and one called PD-1 has shown a great promise and has educated both doctors and scientists. This drug has been researched to target the body’s immune system by, which will allow your body to stop fighting the tumor and allows the immune system to actually fight the cancerous tumor cells.
A vaccine created from patients own cells much like the DNA research study is providing very helpful promise with patients diagnosed with brain cancer, according to a new study. The vaccine called HSPPC-96 uses the patients own infected tumor cells to assist the patients immune system fight the disease. This vaccine is proving to provide great promise, but it has been a lot more challenging to treat than scientist have hoped for. With the brain cancer called Glioblastoma which cause approximately 17,000 diagnosed patients every year and after diagnosis usually patients have about 5 years